Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators, have further elucidated how ovarian cancer tumors defy immunotherapy, identifying new molecular targets that might boost immune response.
Asian and Hispanic communities experience significantly more air pollution from economic activity compared to predominantly white neighborhoods across the state of California, according to new research from the University of California San Diego’s School of Global Policy and Strategy.
For the first time in 15 years, UC San Diego structural engineering students hosted the American Society of Civil Engineers’ Pacific Southwest Symposium, drawing students from 14 universities to campus for civil and structural engineering challenges.
Two global leaders are joining strengths in a broad new effort to advance the discovery and innovation needed to address complex scientific challenges. UC San Diego and Thermo Fisher Scientific have agreed to form a transformational 10-year strategic partnership.
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
Within the University of California system, the student population of 294,000 is an expanding kaleidoscope of experiences and backgrounds: nearly 40 percent are first-generation university students… 34 percent come from low-income backgrounds… 27 percent are racial and ethnic minorities.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
